Valley fever which is also known as coccidioidomycosis, it is a fungal infection with the name Coccidioides fungus. This type of fungus is commonly found in soil and dust of various parts of the world mainly the Americas region.

Scope of the Report:
The global Valley Fever Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Valley Fever Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Valley Fever Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Valley Fever Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
Novartis
Pfizer
GlaxoSmithKline
Johnson & Johnson
Galderma
Bristol Meyer Squibb
Bausch Health Companies

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Fluconazole
Itraconazole
Voriconazole
Posaconazole
Others

Market Segment by Applications, can be divided into
People
Cattle
Sheep and Goats
Camel
Others